Galmed Pharmaceuticals Ltd. buy Piper Sandler
Start price
09.05.25
/
50%
€6.40
Target price
09.05.26
€71.34
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 09.05.26. The prediction end date can be changed by Piper_Sandler at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by Piper_Sandler for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target lowered by analysts at Piper Sandler from $100.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Piper_Sandler for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
06.11.24
06.11.24
€93.31
06.11.25
06.11.25
-
07.11.25
07.11.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.37
20.05.24
20.05.24
€73.65
20.05.25
20.05.25
1648.63%
21.05.25
21.05.25